Prognostic Value of Systemic Immune-Inflammation Index in Predicting Premature Saphenous Vein Graft Disease in Patients With Coronary Artery Bypass Grafting

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 8; p. e42833
• Main Authors: Oguz, Mustafa, Torun, Akin
• Format: Journal Article
• Language: English
• Published: Palo Alto Cureus Inc 02.08.2023; Cureus
• Subjects: Acute coronary syndromes; Age; Angina pectoris; Anticoagulants; Atherosclerosis; Blood; Blood platelets; Cardiac/Thoracic/Vascular Surgery; Cardiology; Cardiovascular disease; Chronic illnesses; Confidence intervals; Coronary vessels; Diabetes; Enzymes; Heart failure; Heart surgery; Hemoglobin; High density lipoprotein; Hypertension; Kidney diseases; Lipoproteins; Medical imaging; Medical prognosis; Regression analysis; Risk factors; Statins; Statistical analysis
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.42833

Background: Systemic inflammation is a risk factor for premature coronary artery disease (CAD), and systemic immune-inflammation index (SII), a new marker of systemic inflammation, is linked to the severity and prognosis of CAD. However, the prognosis of the SII in bypass patients' venous saphenous grafts has not been adequately evaluated. This study aimed to evaluate the prognostic value of SII in predicting premature saphenous vein graft disease (SVGD) in patients who underwent bypass surgery with venous saphenous grafts.Methods: We retrospectively included 422 patients who had saphenous vein grafts (SVG) at least one year after bypass surgery. Of these, 222 patients had SVGD, and 200 had patent SVG.Results: SII was higher in the SVGD group than in the control group (631.55 ± 397.84, 421.71 ± 351.07, P=0.001). A receiver operating characteristic (ROC) analysis was performed to identify the optimal cutoff point with the highest sensitivity and specificity. The optimal cutoff point for SII was defined as 430. Using a cutoff level of >430, SII predicted SVGD with a sensitivity of 73% and specificity of 56%.Conclusion: Our study demonstrated that SII was substantially higher in patients with SVGD than in those with patent SVG. SII predicted SVGD in bypass surgery patients. SII may be a helpful parameter for identifying patients at high risk of SVGD and guiding preventive treatments.